跳至主要内容
临床试验/NCT04364126
NCT04364126招募中不适用

Home Blood Pressure Monitoring in Kidney Transplant Recipients to Alleviate Hypertension - a Pragmatic, Registry-based, Randomized Controlled Study

Oslo University Hospital1 个研究点 分布在 1 个国家目标入组 458 人开始时间: 2022年12月15日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
458
试验地点
1
主要终点
Office systolic blood pressure (BP)

研究概览

简要总结

Randomized controlled study of home blood pressure monitoring in kidney transplant recipients.

详细描述

Adult kidney transplant recipients (n=458) will be randomized 1:1 to standard-of-care (SOC) or home blood pressure measurement (HBPM). The SOC group will target office blood pressure <130/80 mmHg. The HBPM group will measure BP at home, twice morning and evening for (3-)7 days before routine clinical visits (ideally 28 measurements); the mean value from day 2-7 is used; target home mean BP is < 125/80 mmHg.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Kidney transplant recipient
  • •Male or female subject ≥ 18 years old
  • •Any or more of the following at the baseline clinic
  • •Conventional office BP ≥130 mmHg systolic and/or ≥ 80 mmHg diastolic
  • •HBPM ≥125 mmHg systolic and/or ≥ 80 mmHg diastolic measured within the last 3 months (see appendix 1 for details on methodology)
  • •Daytime ambulatory blood pressure monitoring (ABPM) ≥125 mmHg systolic and/or ≥ 80 mmHg diastolic measured within the last 3 months
  • •Signed informed consent and expected cooperation of the patient for the treatment and follow up.
  • •Have a national personal identification number and not be expected to emigrate during study
  • •Enlisted in the Norwegian Renal Registry

排除标准

  • •Standing systolic BP < 110 mmHg (to avoid adverse events). Measured after one and three minutes of standing. Not applicable if unable to stand due to wheelchair use.
  • •Diagnosed atrial fibrillation (automated monitors not validated)
  • •Unwilling to self-monitor
  • •Female participant who is pregnant, lactating or planning pregnancy during the trial (management of essential hypertension in pregnancy is different)
  • •Arm circumference too large or small to allow accurate BP measurement with available device (22-42 cm).
  • •Any reason likely limiting adherence to interventions, as judged by the investigator; examples include active alcohol or substance abuse within the last 12 months, significant poor compliance with medications or attendance at clinic visits, residence in a nursing home, dementia, other medical or psychiatric conditions that may interfere with study participation.
  • •Graft- or life expectancy less than 2 years, as judged by the investigator.
  • •Current use of ≥ 4 antihypertensive medications
  • •More than half of regular appointments planned as remote (e.g. phone or video) consultations.
  • •Severe white-coat hypertension, e.g. patients already treated solely based on home BP values.
  • •Multi-organ transplants (e.g. heart, lung, liver), though pancreas or beta-cell islet transplant is allowed.

研究组 & 干预措施

Standard of care

Active Comparator

Clinical blood pressure measured at regular visits

干预措施: Clinic blood pressure (Other)

Home blood pressure monitoring

Experimental

Home blood pressure measured daily for 1 week before regular clinical visits

干预措施: Home blood pressure apparatus (Device)

结局指标

主要结局

Office systolic blood pressure (BP)

时间窗: 1 year

As reported to Norwegian Renal Registry

次要结局

  • Number of BP lowering medications(1 year)
  • Concentration of plasma creatinine(1 year)
  • Office diastolic BP(1 year)
  • Treatment satisfaction(1 year)
  • Urine protein/creatinine ratio(1 year)
  • Proportion with BP below target (office BP <130/80 mmHg)(1 year)

研究者

发起方
Oslo University Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Dag Olav Dahle

Principal Investigator

Oslo University Hospital

研究点 (1)

Loading locations...

相似试验